Silence Therapeutics plc
SLN· Nasdaq
Released May 7, 2026, before the open
10-Q filed May 7, 2026, 37 days after period end · 0001193125-26-210446
| Metric | Q1 2026 | Q1 2025 | Q1 2024 |
|---|---|---|---|
| Revenue | $422.00K | $142.00K | $15.70M |
| Net Income | -$14.96M | -$28.53M | -$2.31M |
| EPS Diluted | -$0.11 | -$0.20 | -$0.02 |
Silence Therapeutics plc · CIK 1479615 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.